MedPath

GALENA BIOPHARMA, INC.

GALENA BIOPHARMA, INC. logo
🇺🇸United States
Ownership
Private, Subsidiary
Established
2003-01-01
Employees
51
Market Cap
-
Website
http://galenabiopharma.com

Clinical Trials

8

Active:5
Completed:3

Trial Phases

3 Phases

Phase 1:5
Phase 2:1
Phase 3:1

Drug Approvals

1

FDA:1

Drug Approvals

Abstral

Approval Date
Nov 30, 2014
FDA

Clinical Trials

Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials

Phase 1
5 (71.4%)
Phase 2
1 (14.3%)
Phase 3
1 (14.3%)

A Study of Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow Disorders

Phase 2
Completed
Conditions
Thrombocytosis
Myeloproliferative Neoplasms
Interventions
First Posted Date
2014-04-29
Last Posted Date
2017-02-27
Lead Sponsor
Galena Biopharma, Inc.
Target Recruit Count
18
Registration Number
NCT02125318
Locations
🇺🇸

East Valley Hematology and Oncology Medical Group, Burbank, California, United States

🇺🇸

California Cancer Associates for Research & Excellence (cCARE), Escondido, California, United States

🇺🇸

California Cancer Associates For Research and Excellence, Fresno, California, United States

and more 6 locations

Observational Registry Study of Quality of Life When Treating BTcP With Abstral

Completed
Conditions
Quality of Life
Breakthrough Cancer Pain
Interventions
First Posted Date
2013-09-06
Last Posted Date
2015-11-05
Lead Sponsor
Galena Biopharma, Inc.
Target Recruit Count
164
Registration Number
NCT01936636
Locations
🇺🇸

Physicians Pain Specialists of Alabama, P.C., Mobile, Alabama, United States

🇺🇸

Pain Centers Nationwide, Peoria, Arizona, United States

🇺🇸

Valley Pain Consultants, Scottsdale, Arizona, United States

and more 32 locations

Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence

Phase 3
Completed
Conditions
Breast Cancer With Low to Intermediate HER2 Expression
First Posted Date
2011-11-24
Last Posted Date
2017-02-27
Lead Sponsor
Galena Biopharma, Inc.
Target Recruit Count
758
Registration Number
NCT01479244
Locations
🇺🇸

Alabama Oncology, Bessemer, Alabama, United States

🇺🇸

Physicians Pain Specialists of Alabama, P.C., Mobile, Alabama, United States

🇺🇸

Pain Centers Nationwide, Peoria, Arizona, United States

and more 191 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.